Top Markets
#1 Cortex Cortex +32.55%
#2 龙虾 (Lobster) 龙虾 (Lobster) +16.86%
#3 Akedo Akedo +12.21%
#4 wojak wojak +11.93%
#5 MarsCoin MarsCoin +11.23%
#6 Pons Pons +10.45%
#7 EXOD EXOD +9.04%
#8 The Black Bull The Black Bull +7.87%
#9 Seeker Seeker +7.61%
#10 Official Trump Official Trump +6.67%
Coin of the day
Cortex Cortex
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

300357
Kedudukan dalam Saham #7056
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates as a biopharmaceutical... Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates as a biopharmaceutical enterprise, primarily engaged in the discovery, development, production, and sale of medicinal products. The company's core focus is on pharmaceuticals designed for the diagnosis and management of allergic conditions, which it supplies to both the Chinese domestic market and international clientele. Additionally, its portfolio encompasses various skincare lines and stem cell-related solutions. The firm's main offices are located in Huzhou, China.
Harga Saham
$3.33
Modal Pasaran
$1.74B
Perubahan (1 hari)
-1.67%
Perubahan (1 tahun)
-20.89%
Negara
CN
Perdagangan Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357)

Kategori

Healthcare
Sejarah hasil dividen untuk Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357)
Hasil dividen (TTM) bagi Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (simbol saham: 300357) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
0.57%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
2.01%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
2.74%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
2.69%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
2.47%
US